| Trial registration number
|
NCT04498273 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04498273
|
First author
Last imported at : June 24, 2021, 2 a.m.
Source : ClinicalTrials.gov
|
Jean Connors
|
Contact
Last imported at : June 24, 2021, 2 a.m.
Source : ClinicalTrials.gov
|
jconnors@bwh.harvard.edu
|
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
2020-08-04
|
Recruitment status
Last imported at : Dec. 1, 2021, 11 p.m.
Source : ClinicalTrials.gov
|
Terminated
|
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Adaptive
|
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
multi-center
|
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Nov. 6, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
inclusion:
- covid-19+ in past 14 days
- platelets > 100,000
- egfr > 30ml/min
exclusion:
- hospitalized
- contradiction/ other indication for anti-coagulation
- pregnancy
- active cancer
|
Exclusion criteria
Last imported at : Nov. 6, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
None
|
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
4
|
Funding
Last imported at : Dec. 3, 2022, 4 p.m.
Source : ClinicalTrials.gov
|
Frank C Sciurba
|
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
40
|
Inclusion age max
Last imported at : Nov. 6, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
79
|
Countries
Last imported at : Nov. 6, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
United States
|
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
No restriction on type of patients
|
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
0: No restriction on type of patients
|
Total sample size
Last imported at : June 24, 2021, 2 a.m.
Source : ClinicalTrials.gov
|
657
|
primary outcome
Last imported at : Dec. 3, 2022, 4 p.m.
Source : ClinicalTrials.gov
|
Hospitalization for Cardiovascular/Pulmonary Events
|
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov
|
Phase 3
|
Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "2.5 MG", "treatment_id": 110, "treatment_name": "Apixaban", "treatment_type": "Coagulation modifiers", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "5 MG", "treatment_id": 110, "treatment_name": "Apixaban", "treatment_type": "Coagulation modifiers", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 129, "treatment_name": "Aspirin", "treatment_type": "Coagulation modifiers", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|